UGT79B5 Antibody

What is UGT79B5 and what biological functions does it serve in Arabidopsis thaliana?

UGT79B5 is a member of the uridine diphosphate glucuronosyltransferase (UGT) family in Arabidopsis thaliana. These enzymes catalyze the transfer of glucuronic acid to various substrates, playing crucial roles in plant biochemistry. While the specific function of UGT79B5 remains understudied, its classification within the UGT79 subfamily suggests specialization in glucoside synthesis. UGT enzymes broadly contribute to:

• Metabolism of secondary compounds through glucosylation of phenolics, flavonoids, and phytohormones such as auxins

• Stress response mechanisms through detoxification of reactive oxygen species (ROS) and xenobiotics

• Cell wall modification processes through glycosylation of cell wall components

Based on structural and functional conservation within the UGT79 subfamily, UGT79B5 likely participates in plant defense mechanisms or developmental regulation through specialized glucosylation reactions.

What are the key specifications of commercially available UGT79B5 antibodies?

The UGT79B5 Antibody (CSB-PA878542XA01DOA) is a polyclonal antibody specifically raised against the UGT79B5 protein in Arabidopsis thaliana. Unlike monoclonal antibodies, this polyclonal preparation recognizes multiple epitopes on the antigen, providing robust detection capabilities across different experimental platforms. The antibody has been developed for research applications including Western blotting, immunohistochemistry, and immunoprecipitation, although validation data across all these applications remains limited in peer-reviewed literature.

When comparing UGT79B5 antibodies to other UGT-targeting antibodies, researchers should consider:

How should researchers validate UGT79B5 antibody specificity before experimental use?

Validation of UGT79B5 antibody specificity is essential before conducting definitive experiments. A comprehensive validation protocol should include:

• Western blot validation: Compare wild-type Arabidopsis tissues with UGT79B5 knockout or RNAi-silenced plant lines. A specific antibody should show reduced or absent signal in the knockout/silenced lines.

• Peptide competition assay: Pre-incubate the antibody with excess synthetic UGT79B5 peptide (corresponding to the immunogen) before application to samples. Specific binding should be blocked by the peptide.

• Cross-reactivity assessment: Test the antibody against recombinant proteins from closely related UGT family members to confirm specificity within the UGT79 subfamily.

• Immunoprecipitation followed by mass spectrometry: Confirm that the antibody pulls down UGT79B5 rather than related proteins.

• Tissue expression pattern analysis: Compare antibody-based detection patterns with known mRNA expression patterns from transcriptomic data.

These validation steps are particularly important given the limited functional data available for UGT79B5 and potential cross-reactivity with closely related enzymes in the UGT79 subfamily.

What are the optimal experimental conditions for UGT79B5 antibody use in immunolocalization studies?

For effective immunolocalization of UGT79B5 in plant tissues, researchers should optimize several key parameters:

• Fixation protocol: For Arabidopsis tissues, a 4% paraformaldehyde fixation in PBS (pH 7.4) for 2-4 hours at room temperature preserves antigenicity while maintaining cellular structure. Overfixation should be avoided as it may mask epitopes.

• Antigen retrieval: Heat-mediated antigen retrieval in citrate buffer (pH 6.0) for 15-20 minutes improves antibody accessibility to the target protein, particularly in heavily crosslinked samples.

• Blocking and antibody dilution: A 5% BSA blocking solution minimizes non-specific binding. The UGT79B5 antibody should be tested at multiple dilutions (typically 1:100 to 1:1000) to determine optimal signal-to-noise ratio.

• Detection system: Fluorescent secondary antibodies provide superior spatial resolution compared to chromogenic systems, allowing co-localization with organelle markers.

• Controls: Always include:

  • Primary antibody omission control

  • Secondary antibody only control

  • Peptide competition control

  • UGT79B5 knockout/knockdown tissue (if available)

Because UGT enzymes may relocalize under stress conditions, careful sample preparation and consistent handling between experimental groups is essential for meaningful comparisons.

How can researchers design experiments to investigate UGT79B5 function in stress response pathways?

To effectively investigate UGT79B5's role in plant stress responses, a multi-faceted experimental approach is recommended:

• Expression profiling: Monitor UGT79B5 expression (protein and mRNA) under different stress conditions (drought, salt, pathogen infection, oxidative stress) through:

  • Western blotting with the UGT79B5 antibody

  • RT-qPCR for transcript analysis

  • Promoter-reporter fusions to visualize spatial expression patterns

• Genetic manipulation:

  • Generate UGT79B5 knockout lines using CRISPR/Cas9

  • Create overexpression lines under constitutive and inducible promoters

  • Develop complementation lines expressing UGT79B5 variants with altered catalytic domains

• Metabolomic analyses:

  • Compare glycosylated metabolite profiles between wild-type and UGT79B5 mutant plants under stress conditions

  • Use liquid chromatography-mass spectrometry to identify specific substrates

• Phenotypic characterization:

  • Measure stress tolerance parameters (growth, photosynthetic efficiency, ROS accumulation)

  • Quantify cell wall composition changes in response to stress

• Protein interaction studies:

  • Use immunoprecipitation with the UGT79B5 antibody followed by mass spectrometry to identify interacting partners

  • Validate interactions through yeast two-hybrid or bimolecular fluorescence complementation

This comprehensive approach allows researchers to establish both the biochemical function and physiological relevance of UGT79B5 in stress response pathways.

What methods can be used to study UGT79B5 enzyme kinetics and substrate specificity?

Investigating UGT79B5 enzyme kinetics and substrate specificity requires a combination of in vitro and in vivo approaches:

• Recombinant protein production:

  • Express tagged UGT79B5 in E. coli, yeast, or insect cell systems

  • Purify using affinity chromatography

  • Confirm identity and activity using the UGT79B5 antibody in Western blots

• In vitro enzyme assays:

  • Screen potential substrates (flavonoids, phenolics, hormones)

  • Measure reaction rates at varying substrate and UDP-glucose concentrations

  • Calculate kinetic parameters (Km, Vmax, kcat) for each substrate

  • Compare with other UGT family members to establish specificity

• Structural analysis:

  • Perform substrate docking simulations if crystal structures are available

  • Mutate key residues in the predicted binding pocket to confirm their role

  • Use the UGT79B5 antibody to confirm proper folding of mutant proteins

• In vivo validation:

  • Introduce UGT79B5 into knockout backgrounds and measure restoration of glycosylated metabolites

  • Use stable isotope labeling to track substrate conversion in planta

• Inhibitor studies:

  • Test specificity of UGT inhibitors against purified UGT79B5

  • Validate inhibitor effects in plant systems using the antibody to confirm UGT79B5 expression levels remain unchanged

These methodologies allow systematic characterization of UGT79B5's biochemical properties and biological substrates, critical information currently lacking in the scientific literature.

How can UGT79B5 antibody be utilized in analyzing protein-protein interactions and complex formation?

The UGT79B5 antibody can serve as a powerful tool for investigating protein-protein interactions through several advanced techniques:

• Co-immunoprecipitation (Co-IP):

  • Use the UGT79B5 antibody to pull down UGT79B5 complexes from plant lysates

  • Identify interacting partners through Western blotting or mass spectrometry

  • Verify interactions under different physiological conditions (development stages, stress responses)

  • Compare interaction profiles between wild-type and mutant plants

• Proximity-dependent labeling:

  • Generate UGT79B5 fusions with BioID or APEX2

  • Use the UGT79B5 antibody to confirm expression and localization

  • Identify proteins in close proximity to UGT79B5 in vivo

  • Map the spatial organization of UGT79B5-containing complexes

• Super-resolution microscopy:

  • Employ immunofluorescence with the UGT79B5 antibody and fluorophore-conjugated secondary antibodies

  • Use techniques like STORM or PALM to visualize nanoscale protein assemblies

  • Perform multi-color imaging to examine co-localization with potential partners

• Förster Resonance Energy Transfer (FRET):

  • Label UGT79B5 antibody and partner protein antibodies with suitable FRET pairs

  • Measure energy transfer to determine close associations in fixed or live cells

  • Quantify interaction dynamics under different conditions

These approaches can reveal whether UGT79B5 functions in isolation or as part of larger metabolic complexes, potentially explaining its role in coordinating stress responses or developmental processes.

What strategies should researchers employ when facing contradictory results with UGT79B5 antibody detection?

When researchers encounter contradictory results using the UGT79B5 antibody, a systematic troubleshooting approach is essential:

• Antibody validation reassessment:

  • Repeat specificity tests including Western blotting against recombinant UGT79B5

  • Perform peptide competition assays with increasing peptide concentrations

  • Test multiple antibody lots if available

• Sample preparation variations:

  • Compare different protein extraction methods (native vs. denaturing)

  • Evaluate the impact of tissue fixation protocols on epitope accessibility

  • Test for post-translational modifications that might mask epitopes

• Technical considerations:

  • Validate detection systems (HRP vs. fluorescent secondaries)

  • Optimize incubation conditions (temperature, time, buffer composition)

  • Compare results across multiple experimental platforms (Western blot, IHC, flow cytometry)

• Biological variables:

  • Assess protein expression at different developmental stages

  • Compare results across different tissues or cell types

  • Consider stress or environmental conditions that might affect expression

• Independent validation:

  • Develop alternative detection methods (RNA expression, promoter reporter lines)

  • Use mass spectrometry for protein identification

  • Generate knockout/knockdown lines as negative controls

When publishing contradictory findings, researchers should document all optimization attempts and validation methods to ensure transparency and reproducibility.

How can UGT79B5 antibody be adapted for high-throughput screening applications?

Adapting the UGT79B5 antibody for high-throughput screening requires optimization of several parameters:

• Antibody immobilization strategies:

  • Covalent attachment to activated surfaces (ELISA plates, microarrays)

  • Orientation-specific immobilization through Protein A/G or streptavidin-biotin systems

  • Nanoparticle conjugation for enhanced sensitivity and multiplexing capabilities

• Assay miniaturization:

  • Optimize antibody and sample volumes for 384- or 1536-well formats

  • Develop homogeneous (mix-and-read) assay formats to minimize washing steps

  • Standardize positive and negative controls for plate normalization

• Detection technologies:

  • Time-resolved fluorescence for improved signal-to-noise ratio

  • Electrochemiluminescence for enhanced sensitivity

  • Alphascreen or similar proximity-based detection systems for protein interactions

• Automation integration:

  • Robotic liquid handling for consistent antibody and sample dispensing

  • Automated incubation and washing systems

  • High-content imaging platforms for spatial information

• Data analysis pipeline:

  • Implement quality control metrics (Z′ factor, signal window, coefficient of variation)

  • Develop algorithms for hit identification and classification

  • Integrate with existing plant phenotypic and genetic databases

These adaptations enable screening of:

• UGT79B5 expression across germplasm collections

• Chemical libraries for UGT79B5 inhibitors or activators

• Environmental conditions affecting UGT79B5 expression or activity

What are the most common pitfalls when using UGT79B5 antibody in plant tissue analyses?

Researchers commonly encounter several challenges when using UGT79B5 antibody for plant tissue analyses:

• High background signal:

  • Caused by: Insufficient blocking, excessive antibody concentration, or cross-reactivity

  • Solution: Optimize blocking with 5% BSA or specialized plant blocking buffers containing non-plant proteins; titrate antibody concentration; include competitive binding controls

• Weak or absent signal:

  • Caused by: Epitope masking during fixation, low target abundance, or poor antibody quality

  • Solution: Test multiple fixation protocols; concentrate protein samples; use signal amplification systems like tyramide signal amplification (TSA)

• Non-specific bands on Western blots:

  • Caused by: Cross-reactivity with related UGT family members

  • Solution: Increase stringency of washing steps; perform peptide competition assays; use tissues from UGT79B5 knockout plants as negative controls

• Inconsistent results between replicates:

  • Caused by: Sample heterogeneity or antibody instability

  • Solution: Standardize tissue collection and processing; aliquot antibody stocks to avoid freeze-thaw cycles; include positive control samples in each experiment

• Discrepancies between protein and mRNA expression data:

  • Caused by: Post-transcriptional regulation or antibody specificity issues

  • Solution: Perform time-course studies; use multiple antibodies targeting different epitopes; validate with tagged UGT79B5 expression systems

Detailed documentation of all optimization steps is essential for publications, as the limited available data on UGT79B5 means each lab must establish reliable protocols independently.

How should researchers optimize protein extraction protocols for UGT79B5 detection in different plant tissues?

Optimizing protein extraction for UGT79B5 detection requires tissue-specific considerations:

• Leaf tissue extraction:

  • Buffer composition: 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, 1 mM EDTA

  • Critical additives: 1 mM DTT, plant-specific protease inhibitor cocktail, 1% PVPP to remove phenolics

  • Homogenization: Liquid nitrogen grinding followed by brief sonication

  • Centrifugation: 15,000 × g for 20 minutes at 4°C to remove debris

• Root tissue extraction:

  • Buffer modifications: Increase detergent concentration to 1.5% Triton X-100

  • Additional steps: Extended washing in PBS to remove soil contaminants

  • Critical considerations: Higher levels of interfering compounds require additional purification steps

• Reproductive tissues (flowers, siliques):

  • Buffer modifications: Add 10% glycerol to stabilize proteins

  • Homogenization: Gentler disruption methods to preserve protein integrity

  • Filtration: Use multiple filtration steps to remove tissue debris

• Subcellular fractionation for localization studies:

  • Perform differential centrifugation to isolate organelles

  • Extract proteins from each fraction with buffer optimized for that compartment

  • Use the UGT79B5 antibody to track protein distribution across fractions

• Western blot optimization:

  • Protein loading: 20-50 μg total protein per lane

  • Transfer conditions: Semi-dry transfer at 15V for 30-45 minutes

  • Blocking: 5% non-fat milk or BSA in TBST for 1 hour

  • Antibody dilution: Start with 1:1000 and optimize as needed

By systematically optimizing these parameters for each tissue type, researchers can ensure consistent and reliable UGT79B5 detection across experiments.

What considerations are important when using UGT79B5 antibody in transgenic plant systems?

When employing UGT79B5 antibody in transgenic plant systems, researchers should address several key considerations:

• Epitope modifications:

  • If UGT79B5 is tagged (FLAG, HA, GFP), ensure the tag doesn't interfere with antibody binding

  • For fusion proteins, confirm the epitope remains accessible in the tertiary structure

  • Consider using both anti-tag and anti-UGT79B5 antibodies for validation

• Expression level effects:

  • Overexpression may lead to protein aggregation or mislocalization

  • Calibrate antibody dilutions based on expression levels

  • Include wild-type controls at matched exposure settings to assess background

• Promoter considerations:

  • Native promoter constructs maintain physiological expression patterns

  • Inducible systems require time-course analyses to determine optimal detection windows

  • Tissue-specific promoters may require modified extraction protocols

• Post-translational modifications:

  • Check if transgenic expression affects glycosylation or phosphorylation patterns

  • Confirm that modified forms are still recognized by the antibody

  • Consider phosphatase or glycosidase treatments to assess modification effects

• Knockout/knockdown validation:

  • Use the antibody to confirm complete protein absence in knockout lines

  • For RNAi or CRISPR lines, quantify the degree of protein reduction

  • Assess specificity by confirming non-detection of truncated proteins

These considerations ensure accurate interpretation of results when using the UGT79B5 antibody in transgenic systems, particularly important when characterizing novel functions or regulatory mechanisms.

How might advances in antibody engineering improve UGT79B5 detection specificity and sensitivity?

Emerging antibody engineering technologies offer promising avenues to enhance UGT79B5 detection:

• Single-domain antibodies (nanobodies):

  • Smaller size (15 kDa vs. 150 kDa) enables better tissue penetration

  • Higher stability under varying pH and temperature conditions

  • Potential for epitope-specific recognition of UGT79B5 catalytic domains

  • Applications in super-resolution microscopy and intracellular tracking

• Recombinant antibody fragments:

  • Fab or scFv fragments with enhanced specificity for UGT79B5-unique epitopes

  • Reduced background through elimination of Fc-mediated binding

  • Potential for bacterial expression systems decreasing production costs

  • Improved consistency between antibody batches

• Affinity maturation technologies:

  • Directed evolution approaches to enhance UGT79B5 binding affinity

  • Phage display selection for specificity against related UGT family members

  • Rational design of complementarity-determining regions (CDRs)

• Multi-specific antibody formats:

  • Bispecific antibodies targeting UGT79B5 and interaction partners simultaneously

  • Proximity-based detection systems using split reporter complementation

  • Antibody-DNA conjugates for digital counting applications

• Chemical modifications:

  • Site-specific conjugation of fluorophores or enzymes

  • Oriented immobilization strategies for biosensor applications

  • Antibody-drug conjugates for targeted inhibition studies

These advances could overcome current limitations in UGT79B5 research by providing tools with improved specificity, sensitivity, and application versatility.

What emerging technologies might complement UGT79B5 antibody-based detection methods?

Several cutting-edge technologies are poised to complement traditional antibody-based UGT79B5 detection:

• Proximity labeling proteomics:

  • Fusion of UGT79B5 with BioID, APEX2, or TurboID enzymes

  • In vivo biotinylation of proximal proteins

  • Mass spectrometry identification of the UGT79B5 interaction network

  • Spatial mapping of UGT79B5-containing complexes in different cellular compartments

• CRISPR-based tagging systems:

  • Endogenous tagging of UGT79B5 to avoid overexpression artifacts

  • Split-fluorescent protein complementation for visualizing interactions

  • Degron-based systems for rapid protein depletion studies

  • CRISPRa/CRISPRi for modulating UGT79B5 expression levels

• Single-cell omics integration:

  • Combining scRNA-seq with antibody-based protein detection

  • Spatial transcriptomics aligned with immunohistochemistry

  • Correlation of UGT79B5 protein levels with metabolomic profiles

  • Cell-type specific analysis of UGT79B5 function

• Microfluidic and organ-on-chip systems:

  • Monitoring UGT79B5 expression in response to precisely controlled stimuli

  • Real-time analysis of enzyme activity and metabolite production

  • High-throughput screening of environmental conditions

  • Testing substrate specificity in physiologically relevant contexts

• Computational approaches:

  • Machine learning for antibody epitope prediction and optimization

  • Molecular dynamics simulations of UGT79B5-substrate interactions

  • Network analysis integrating protein, metabolite, and phenotypic data

  • Virtual screening for novel inhibitors or enhancers

Integration of these technologies with traditional antibody-based methods will provide unprecedented insights into UGT79B5 function and regulation in plant systems.

How can researchers contribute to improving the characterization and validation of UGT79B5 antibodies?

Researchers can advance UGT79B5 antibody validation through several collaborative approaches:

• Standardized validation protocols:

  • Develop community-accepted guidelines for UGT79B5 antibody validation

  • Establish minimum reporting standards for antibody characterization

  • Create open-access validation datasets for commercially available antibodies

  • Perform interlaboratory studies to assess reproducibility

• Expanded genetic resources:

  • Generate UGT79B5 knockout lines in multiple ecotypes

  • Develop allelic series with point mutations in different domains

  • Create epitope-tagged reference lines for antibody validation

  • Establish inducible expression systems for controlled validation

• Advanced epitope mapping:

  • Perform hydrogen-deuterium exchange mass spectrometry to identify binding sites

  • Use X-ray crystallography or cryo-EM to resolve antibody-antigen complexes

  • Develop epitope-specific antibodies targeting distinct UGT79B5 domains

  • Map cross-reactivity with other UGT family members

• Data repositories and resources:

  • Contribute validation data to antibody validation databases (e.g., Antibodypedia)

  • Share optimized protocols through platforms like Protocol Exchange

  • Deposit immunoprecipitation-mass spectrometry datasets in public repositories

  • Create searchable libraries of UGT79B5 expression patterns across conditions

• Application expansion:

  • Validate UGT79B5 antibodies for new techniques (ChIP-seq, CUT&RUN, etc.)

  • Develop quantitative assays for absolute protein quantification

  • Test cross-species reactivity for comparative studies

  • Optimize for challenging sample types (fixed tissues, low abundance samples)

These collaborative efforts would substantially improve research reproducibility and accelerate discoveries related to UGT79B5 function in plant biology.